Clin2
NCT07665073Possibly a fitNot yet recruiting

Comparing two medicines for bipolar mania

Bipolar 1 Disorder

Treatments studied

Part of Mental health clinical trials.

This trial compares two medications, risperidone and cariprazine, to see which works better for treating acute mania in bipolar disorder. If you are experiencing a manic episode, this study might help find a treatment that works well for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
50 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have bipolar disorder and are currently having a manic episode (very high mood, energy, or agitation).
  • You are not currently taking other antipsychotic medications.
  • You do not have a substance use problem (like drugs or alcohol).
  • Your mania is not caused by another medical condition.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05913947Recruiting· Phase 4
Lithium or cariprazine for bipolar depression

This trial compares lithium versus cariprazine to treat an episode of depression in people with bipolar disorder. It may help find which medicine works better and is safer during the acute (active) phase of depression.

Aalborg
NCT07676669Not yet recruiting· Phase 4
Lumateperone vs cariprazine for bipolar I depression

This study compares two oral medications, lumateperone and cariprazine, to see which is more effective and safer for treating depression in bipolar I disorder. It aims to help reduce depressive symptoms and improve overall well-being.

NCT06589817Not yet recruiting· Phase 3
Comparing two antipsychotic medications for acute schizophrenia

This study tests whether a new medication, cariprazine, works as well as an older one, aripiprazole, for people having a recent episode of schizophrenia. Participants will receive one of the two drugs for a set period, and the study will track how well symptoms improve.

NCT05933538Not yet recruiting· Phase 4
Cariprazine for treatment of major depression

This trial tests whether cariprazine, an antipsychotic medication, can help treat major depression in people who are currently having a depressive episode. The study will see if taking cariprazine alone improves mood and depression symptoms.

NCT04777357Recruiting· Phase 3
Cariprazine for bipolar depression in ages 10 to 17

This Phase 3 study tests whether cariprazine can improve depression symptoms in children and teens with bipolar I disorder, and also tracks side effects. It may help if your depressive episode is ongoing and you meet specific mood and screening score requirements.

Bentonville, Arkansas
NCT07185815Recruiting· Phase 1/Phase 2
Study of a long-acting cariprazine shot for mood and schizophrenia

This trial tests a monthly injection of cariprazine (a medication for mental health conditions) in people who could benefit from it. It aims to see if the shot is safe, tolerable, and effective compared to taking pills every day.

Ahmedabad

Hear when a new Bipolar 1 Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.